Indiana Jones’ greatest fear may be obesity’s biggest enemy. Scientists at three universities have turned to nature to find a property that rivals the benefits of GLP-1 drugs without the laundry list of side effects. What they’ve discovered, in the cold blood of a creature that grows up to 33 feet long, is poised to … Read more
The GLP-1 PR has been a little too good. Everyone knows the drugs lead to rapid weight loss — including participants in supposedly “blind” drug trials. So now, when those participants don’t drop pounds, they drop out. Pharmaceutical manufacturers are reporting widespread instances of patients quitting their clinical trials prematurely once they realize they’ve been … Read more
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Magic pills promising to help overweight people slim down are nothing new. When I was a teenager on Staten Island, back when ephedra was still legal, I bought a bottle … Read more
Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under brand names like Ozempic have helped millions of people lose weight, manage diabetes and improve other health conditions, they are not without risks. Check back for more stories about the lesser-known downsides of … Read more
Too much of a good thing? Participants taking the highest dose of Eli Lilly’s new GLP-1 drug lost an average of 28.7% of their body weight in a late-stage trial, putting it on track to be a heavyweight in the crowded world of weight-loss and diabetes treatments. But in a surprising twist, top-line results show … Read more
You’ve likely heard of diabetes, a chronic condition that affects how the body regulates blood sugar. But are you familiar with prediabetes? Prediabetes is a state of elevated blood sugar that falls below the threshold of Type 2 diabetes. It’s becoming increasingly common: More than 1 in 3 US adults has prediabetes, and most aren’t … Read more
Too good to be true? While blockbuster GLP-1 drugs continue to reach new heights in popularity, they’re not without potential downsides, like bizarre side effects such as “Ozempic feet.” And while they boast impressive blood sugar and weight loss results — average weight lost is nearly 10% over a year — making one mistake could … Read more
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. With weight loss drugs taking the world by storm, more people are exploring adding these medical marvels to their toolkits. Aside from the impressive results, GLP-1s seem to be increasingly … Read more
“Dry January” is getting replaced by something a lot more modern: half of Americans say taking GLP-1 medications is the next big wellness trend. The poll of 2,000 US adults found nearly a quarter (23%) currently use GLP-1s or have used them within the past five years. And when asked if they would rather ditch … Read more
About one in eight Americans have tried GLP-1 drugs like Mounjaro, Zepbound and Ozempic — and they’ve shrunken appetites so dramatically that people are spending noticeably less on groceries. But one dietitian and LillyDirect partner — a platform from Eli Lilly, which sells Mounjaro and Zepbound — tells The Post there are actually lots of … Read more
Here’s the skinny on Chipotle’s new “GLP-1 friendly” menu. This coming Tuesday, Chipotle will debut its High Protein Menu –and it proves how weight-loss drugs such as Ozempic and Wegovy are altering the way people eat. “With the rise of GLP-1s and a broader focus on macronutrients, Chipotle’s new High Protein Menu offers more ways … Read more
There’s trouble brewing beneath the GLP-1 buzz. As Americans embrace blockbuster weight-loss drugs like Ozempic and Wegovy in record numbers, providers are warning of a troubling ripple effect: patients sliding back into restrictive eating disorders — and others developing them for the first time. “I think there should be a button that you have to … Read more
The world’s first GLP-1 weight loss treatment is being administered for pets on an experimental basis. The first cat was successfully dosed in the MEOW-1 study of OKV-119 – an investigational “ultra-long acting” GLP-1 implant, which, according to a press release, is being developed for weight management in cats. OKAVA Pharmaceuticals, the San Francisco-based manufacturer of the … Read more
With new agreements from President Donald Trump promising lower prices on popular weight-loss drugs, the use of GLP-1 medications such as Ozempic and Mounjaro could soon surge even higher — a trend already spreading unevenly across the US, with some states seeing greater uptick than others. Based on insurance claims data from Purple Lab, a Pennsylvania … Read more
Forget New Year’s resolutions — weight loss experts say the best time to slim down might actually be right now. “October Theory — the idea that fall brings a natural reset as routines stabilize after summer — is a great framework for those seeking weight loss and a boost to their overall health,” Dr. Holly … Read more
Oprah has long been the ultimate weight loss influencer — but some other stars are coming for her crown. After the former talk show host signed up as a Weight Watchers ambassador, the company signed up a million new members in just a year — and her December 2023 revelation about using GLP-1 drugs inspired … Read more
Americans are jumping for jabs. Surveys show at least one in eight US adults have given GLP-1s drugs like Ozempic and Wegovy a shot, with 6% currently taking them. The miracle meds have been linked to a host of health benefits beyond diabetes management and weight loss, from staving off Alzheimer’s and curbing addiction to … Read more
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. As GLP-1 firms continue to bulk up, WeightWatchers (WW) is stepping off the scale. The points-system-based weight loss program filed for bankruptcy on May 6, with its premarket value plummeting … Read more
You may soon be able to eat your Ozempic… sort of. GLP-1 supplements are booming, promising to deliver similar benefits to Ozempic and Wegovy without the pricey injections. The latest contender is NotCo’s GLP Booster, a first-of-its-kind botanical powder that you can add to any food to help you eat less — and the brand … Read more
Ozempic maker Novo Nordisk says it has developed a compound that’s shown to be a one-two punch for appetite suppression and weight loss in mice. Ozempic promotes weight loss by mimicking the GLP-1 hormone the body naturally produces after eating, so users feel full for longer. This new potential therapy harnesses the power of GLP-1 … Read more
Losing face? Take heart. There’s a new supplement on the market that promises to put an end to the droopy aesthetic of “Ozempic face” — in addition to some of the other unpleasant side effects of the medication. Ozempic is part of a class of diabetes and obesity drugs that mimic the GLP-1 hormone the … Read more
Why fork over thousands of dollars a month for prescription weight loss jabs when store-bought supplements claim to have the same effect? Trendy GLP-1 supplements are being touted as “nature’s Ozempic”, promising to deliver a similar outcome as the wildly popular injectable — all for a fraction of the price. Ozempic and sister drugs Wegovy … Read more